Drug Profile
Research programme: protease inhibitors - Aspira Womens Health
Alternative Names: Trappin-2Latest Information Update: 16 Jun 2020
Price :
$50
*
At a glance
- Originator Ciphergen Biosystems
- Class Small molecules
- Mechanism of Action Peptide hydrolase inhibitors; Serine endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 11 Jun 2020 Vermillion Inc is now called Aspira Womens Health
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections(Prevention) in USA
- 24 Aug 2007 Ciphergen Biosystems is now called Vermillion